期刊文献+

环孢菌素A对慢性再生障碍性贫血患者Th1/Th2的影响 被引量:1

IMPACT OF CYCLOSPORINE A ON Th1/Th2 IN PATIENTS WITH CHRONIC APLASTIC ANEMIA
下载PDF
导出
摘要 目的观察环孢菌素A(CsA)对慢性再生障碍性贫血(AA)患者Th1/Th2的影响。方法选择30例AA患者,于治疗前及经CsA治疗6个月后分别采用流式细胞术检测其外周血Th1、Th2,采用酶联免疫吸附法检测IFN-γ、IL-4,另选20例健康人作为对照,并进行比较。结果治疗前慢性AA患者Th1、Th1/Th2比值、IFN-γ的表达均明显高于对照组(P<0.01);经CsA治疗6个月后,患者Th1、IFN-γ表达均有所下降,但仍高于对照组(P<0.01)。结论 CsA能通过纠正Th1过度极化而减轻AA异常亢进的细胞免疫,解除造血抑制。 Objective To observe the effect of cyclosporin A(CsA) on Th1/ Th2 in patients with chronic aplastic anemia(AA).Methods As to the 30 cases of AA,low cytometry detection of peripheral blood Th1 and Th2 was done before treatment and 6 months after the use of CsA for treatment respectively,and nzyme-linked immunosorbent assay was used for the detection of IFN-γand IL-4.Another 20 healthy persons were chosed to form the control group.Results Before the treatment,the expressions of Th1,Th1 / Th2 ratio,IFN –γof the patients with chronic AA were all significantly higher than those in the control group(P0.01).After six months of treatment with CsA,the expressions of Th1,Th1 / Th2 ratio,IFN –γof the patients were reduced,but still higher than those of the control group(P0.01).Conclusion Through correcting the excessive Th1 polarization and reducing the abnormal AA hyperfunction of cellular immunity,CsA can help relieve the inhibition of hematopoiesis.
作者 陈为志
机构地区 日照市人民医院
出处 《山东医学高等专科学校学报》 2012年第3期173-174,177,共3页 Journal of Shandong Medical College
关键词 环孢菌素A 再生障碍性贫血 TH1/TH2 Cyclosporine A Aplastic anemia Th1/Th2
  • 相关文献

参考文献1

二级参考文献20

  • 1许崇艳.再生障碍性贫血的免疫抑制治疗[J].中国实验血液学杂志,2005,13(2):348-352. 被引量:24
  • 2王雪梅,韩梅,肖中平,陈琳.环孢素与雄激素联合治疗再生障碍性贫血临床观察[J].中国误诊学杂志,2007,7(3):453-453. 被引量:12
  • 3黄永兰,黄绍良,梁蔚文,魏菁.再生障碍性贫血患儿CD_4^+ CD_(25)^+T细胞及TGF-β1 Flt-3L水平变化的意义[J].中国实用儿科杂志,2007,22(2):130-133. 被引量:9
  • 4Solomou EE, Rezvani K, Mielke S, Malide D, Keyvanfar K, Visconte V, et al. Deficient CD4 + CD25 + FOXP3 + T regulatory cells in acquired aplastic anemia [ J ]. Blood, 2007, 110 (5) : 16031606.
  • 5Fiedler B, Wollert KC. Inter ference of antihypertrophic molecules and signaling pathways with the Ca2 + calcineurin-NFAT cascade in cardiacmy ocytes [J]. Cardiovasc Res, 2004, 63 (3) : 450457.
  • 6Bayer AL, Yu A, Malek TR. Function of the IL-2R for thymie and peripheral CD4 + CD25 + Foxp3 + T regulatory cells[J]. J Immunol, 2007, 178(7) : 4062-4071.
  • 7Lutsiak ME, Semnani RT, De Pascalis R, Kashmiri SV, Schlom J, Sabzevari H. Inhibition of CD4 + CD25 + T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide [ J ]. Blood, 2005, 105 (7) : 2862-2868.
  • 8Godfrey WR, Spoden DJ, Ge YG, Baker SR, Liu B, Levine BL, et al. Cord blood CD4 + CD25 + derived T regulatory ceils linesexpress FOXP3 protein and manifest potent suppressor function [ J ]. Blood, 2005, 105(2) : 750-758.
  • 9Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+ CD25 + regulatory T ceils [ J ]. Nax Immunol, 2003, 4(4) : 330-336.
  • 10Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for scurfin in CD4 + CD25 + T regulatory cells [ J ]. Nat Immunol, 2003, 4(4) : 337-342.

共引文献10

同被引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部